4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000064
Senior Vice President, Finance sold 9,854 shares at an average $69.72 ($687,035)
- Senior Vice President, Finance acquired 9,459 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Agarwal Arjun · Senior Vice President, Finance
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-12 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,000 | $12.50 | $100,000 | 25,294 | D |
| 2026-06-12 | Exercise or conversion : show line 2 in the form 10b5-1 | +1,459 | $34.39 | $50,175 | 26,753 | D |
| 2026-06-12 | Sale : show line 3 in the form 10b5-1 | −1,859 | $68.34 | $127,048 | 24,894 | D |
| 2026-06-12 | Sale : show line 4 in the form 10b5-1 | −4,340 | $69.85 | $303,154 | 20,554 | D |
| 2026-06-12 | Sale : show line 5 in the form 10b5-1 | −3,260 | $70.34 | $229,306 | 17,294 | D |
| 2026-06-15 | Sale : show line 6 in the form 10b5-1 | −395 | $69.69 | $27,528 | 16,899 | D |
| Open-market sales · 9,854 sh · avg $69.72 · $687,035 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-12 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) | −8,000 | 110,000 | D |
| 2026-06-12 | Exercise or conversion : show line 8 in the form 10b5-1 Employee Stock Option (right to buy) | −1,459 | 62,708 | D |
Loading xslF345X06/form4.xml…